124 related articles for article (PubMed ID: 2481)
1. Cardiovascular and beta-adrenergic blocking effects of timolol.
Mouillé P; Schmitt H; Cheymol G; Gauter E
Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
[TBL] [Abstract][Full Text] [Related]
2. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
[No Abstract] [Full Text] [Related]
3. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cardiac effects of timolol and propranolol.
Achong MR; Piafsky KM; Ogilvie RI
Clin Pharmacol Ther; 1975 Sep; 18(3):278-86. PubMed ID: 1100298
[TBL] [Abstract][Full Text] [Related]
5. Timolol maleate, a new beta-adrenergic receptor blocking agent.
Hall RA; Robson RD; Share NN
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
[TBL] [Abstract][Full Text] [Related]
6. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.
Lee RJ; Evans DB; Baky SH; Laffan RJ
Eur J Pharmacol; 1975; 33(2):371-82. PubMed ID: 241655
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
Nakayama K; Oshima T; Koike H
Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
[TBL] [Abstract][Full Text] [Related]
9. Duration of cardiac effects of timolol and propranolol.
Achong MR; Piafsky KM; Ogilvie RI
Clin Pharmacol Ther; 1976 Feb; 19(2):148-52. PubMed ID: 4254
[TBL] [Abstract][Full Text] [Related]
10. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
Masumoto S; Inoue H; Maruyama Y
Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
[No Abstract] [Full Text] [Related]
11. A comparison of the actions of ICI66082 and propranolol on cardiac and peripheral beta-adrenoceptors.
Singh BN; Nisbet HE; Harris EA; Whitlock RM
Eur J Pharmacol; 1975 Nov; 34(1):75-86. PubMed ID: 11998
[TBL] [Abstract][Full Text] [Related]
12. [Drug effects on blood pressure and heart rate in unanesthetized animals. (1). Effects of beta-blocking agents (author's transl)].
Iizuka H; Nakagawa Y; Matsubara I; Imai S; Yanagita T
Nihon Yakurigaku Zasshi; 1977 May; 73(4):401-9. PubMed ID: 20392
[TBL] [Abstract][Full Text] [Related]
13. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
[TBL] [Abstract][Full Text] [Related]
14. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic action of a new beta-adrenergic blocking agent, 6-(2-hydroxy-3-isopropylaminopropyloxy)-benzothiazole succinate (KF-577), compared with that of propranolol.
Tatsuno H; Goto K; Shigenobu K; Kasuya Y
Eur J Pharmacol; 1976 Nov; 40(1):145-52. PubMed ID: 11105
[TBL] [Abstract][Full Text] [Related]
16. A potent new beta2-adrenoceptor blocking agent.
Imbs JL; Miesch F; Schwartz J; Velly J; Leclerc G; Mann A; Wermuth CG
Br J Pharmacol; 1977 Jul; 60(3):357-62. PubMed ID: 19116
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of isoproterenol and possible antagonistic actions of propranolol and perhexiline.
Matsukawa H; Okabe E; Sakamoto H; Cho YW; Ito H
Jpn Circ J; 1978 Apr; 42(4):425-32. PubMed ID: 29976
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
Hastings SG; Smith RD; Corey RM; Essenburg AD; Pettway CE; Tessman DK
Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
[No Abstract] [Full Text] [Related]
20. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.
Yabuuchi Y; Yamashita S; Tei SS
J Pharmacol Exp Ther; 1977 Aug; 202(2):326-36. PubMed ID: 18598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
